1.
Am J Hematol
; 81(3): 210-1, 2006 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16493607
RESUMO
We report occurrence of severe methemoglobinemia in a patient on novel experimental anti-cancer drug, Triapine. Treatment with methylene blue led to massive hemolysis due to concomitant G6PD deficiency. We recommend that G6PD screening be done in high-risk populations prior to commencement of Triapine therapy.